Potential Biomarkers Associated with Differential Manifestations of Ulcerative Colitis (UC) in Uyghur and Han Population in China

References

• Zhou H, Xi L, Ziemek D, et al. Molecular profiling of ulcerative colitis subjects from the TURANDOT trial reveals novel pharmacodynamic/efficacy biomarkers. J Crohns Colitis. 2019;13(6):702–713. doi:10.1093/ecco-jcc/jjy217
   PubMed Web of Science ®Google Scholar
• Malik TA. Inflammatory bowel disease: historical perspective, epidemiology, and risk factors. Surg Clin North Am. 2015;95(6):1105–1122. doi:10.1016/j.suc.2015.07.006
   PubMed Web of Science ®Google Scholar
• Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390(10114):2769–2778. doi:10.1016/S0140-6736(17)32448-0
   PubMed Web of Science ®Google Scholar
• Danese S, Fiocchi C. Ulcerative colitis. N Engl J Med. 2011;365(18):1713–1725. doi:10.1056/NEJMra1102942
   PubMed Web of Science ®Google Scholar
• Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature. 2011;474(7351):307–317. doi:10.1038/nature10209
   PubMed Web of Science ®Google Scholar
• Feuerstein JD, Moss AC, Farraye FA. Ulcerative colitis. Mayo Clin Proc. 2019;94(7):1357–1373. doi:10.1016/j.mayocp.2019.01.018
   PubMed Web of Science ®Google Scholar
• Wehkamp J, Stange EF. Recent advances and emerging therapies in the non-surgical management of ulcerative colitis. F1000Res. 2018;7:1207. doi:10.12688/f1000research.15159.1
   Google Scholar
• Bopanna S, Ananthakrishnan AN, Kedia S, Yajnik V, Ahuja V. Risk of colorectal cancer in Asian patients with ulcerative colitis: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2017;2(4):269–276. doi:10.1016/S2468-1253(17)30004-3
   PubMed Web of Science ®Google Scholar
• Arora G, Mannalithara A, Singh G, Gerson LB, Triadafilopoulos G. Risk of perforation from a colonoscopy in adults: a large population-based study. Gastrointest Endosc. 2009;69(3 Pt 2):654–664. doi:10.1016/j.gie.2008.09.008
   PubMed Web of Science ®Google Scholar
• Ng SC, Kaplan GG, Tang W, et al. Population density and risk of inflammatory bowel disease: a prospective population-based study in 13 countries or regions in Asia-Pacific. Am J Gastroenterol. 2019;114(1):107–115. doi:10.1038/s41395-018-0233-2
   PubMed Web of Science ®Google Scholar
• Gao F, Aheman A, Lu JJ, Abuduhadeer M, Li YX, Kuerbanjiang A. Association of HLA-DRB1 alleles and anti-neutrophil cytoplasmic antibodies in Han and Uyghur patients with ulcerative colitis in China. J Dig Dis. 2014;15(6):299–305. doi:10.1111/1751-2980.12143
   PubMed Web of Science ®Google Scholar
• Aheman A, Luo HS, Gao F. Association of fucosyltransferase 2 gene variants with ulcerative colitis in Han and Uyghur patients in China. World J Gastroenterol. 2012;18(34):4758–4764. doi:10.3748/wjg.v18.i34.4758
   PubMed Web of Science ®Google Scholar
• Aheman A, Gao F, Kuerbanjiang A, Li YX, Abuduhadeer M. Difference in DRB1* gene polymorphisms between Han and Uyghur ulcerative colitis patients in China. World J Gastroenterol. 2013;19(17):2709–2713. doi:10.3748/wjg.v19.i17.2709
   PubMed Web of Science ®Google Scholar
• Muthas D, Reznichenko A, Balendran CA, et al. Neutrophils in ulcerative colitis: a review of selected biomarkers and their potential therapeutic implications. Scand J Gastroenterol. 2017;52(2):125–135. doi:10.1080/00365521.2016.1235224
   PubMed Web of Science ®Google Scholar
• Nakov R. New markers in ulcerative colitis. Clin Chim Acta. 2019;497:141–146. doi:10.1016/j.cca.2019.07.033
   PubMed Web of Science ®Google Scholar
• Lei Y, Chen Y, Lin Z, Tian D, Han P. Comprehensive analysis of key biomarkers, immune infiltration and potential therapeutic agents for ulcerative colitis. Life Sci. 2020;260:118437. doi:10.1016/j.lfs.2020.118437
   PubMed Web of Science ®Google Scholar
• Fefferman DS, Farrell RJ. Endoscopy in inflammatory bowel disease: indications, surveillance, and use in clinical practice. Clin Gastroenterol Hepatol. 2005;3(1):11–24. doi:10.1016/S1542-3565(04)00441-0
   PubMed Web of Science ®Google Scholar
• Flynn S, Eisenstein S. Inflammatory bowel disease presentation and diagnosis. Surg Clin North Am. 2019;99(6):1051–1062. doi:10.1016/j.suc.2019.08.001
   PubMed Web of Science ®Google Scholar
• Shi L, Han X, Li JX, et al. Identification of differentially expressed genes in ulcerative colitis and verification in a colitis mouse model by bioinformatics analyses. World J Gastroenterol. 2020;26(39):5983–5996. doi:10.3748/wjg.v26.i39.5983
   PubMed Web of Science ®Google Scholar
• Zhang J, Wang X, Xu L, Zhang Z, Wang F, Tang X. Investigation of potential genetic biomarkers and molecular mechanism of ulcerative colitis utilizing bioinformatics analysis. Biomed Res Int. 2020;2020:4921387.
   PubMed Web of Science ®Google Scholar
• Han NY, Choi W, Park JM, Kim EH, Lee H, Hahm KB. Label-free quantification for discovering novel biomarkers in the diagnosis and assessment of disease activity in inflammatory bowel disease. J Dig Dis. 2013;14(4):166–174. doi:10.1111/1751-2980.12035
   PubMed Web of Science ®Google Scholar
• Berry D, Reinisch W. Intestinal microbiota: a source of novel biomarkers in inflammatory bowel diseases? Best Pract Res Clin Gastroenterol. 2013;27(1):47–58. doi:10.1016/j.bpg.2013.03.005
   PubMed Web of Science ®Google Scholar
• Rubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG, Long MD. ACG Clinical guideline: ulcerative colitis in adults. Am J Gastroenterol. 2019;114(3):384–413.
   PubMed Web of Science ®Google Scholar
• Irizarry RA, Hobbs B, Collin F, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003;4(2):249–264. doi:10.1093/biostatistics/4.2.249
   PubMed Web of Science ®Google Scholar
• Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47. doi:10.1093/nar/gkv007
   PubMed Web of Science ®Google Scholar
• Agarwal V, Bell GW, Nam JW, Bartel DP. Predicting effective microRNA target sites in mammalian mRNAs. Elife. 2015;4. doi:10.7554/eLife.05005
   Web of Science ®Google Scholar
• Chou CH, Shrestha S, Yang CD, et al. miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions. Nucleic Acids Res. 2018;46(D1):D296–D302. doi:10.1093/nar/gkx1067
   PubMed Web of Science ®Google Scholar
• Chen Y, Wang X. miRDB: an online database for prediction of functional microRNA targets. Nucleic Acids Res. 2020;48(D1):D127–D131. doi:10.1093/nar/gkz757
   PubMed Web of Science ®Google Scholar
• Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284–287. doi:10.1089/omi.2011.0118
   PubMed Web of Science ®Google Scholar
• Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology. Lancet. 2007;369(9573):1627–1640. doi:10.1016/S0140-6736(07)60750-8
   PubMed Web of Science ®Google Scholar
• Ramos GP, Papadakis KA. Mechanisms of disease: inflammatory bowel diseases. Mayo Clin Proc. 2019;94(1):155–165. doi:10.1016/j.mayocp.2018.09.013
   PubMed Web of Science ®Google Scholar
• Tili E, Michaille JJ, Piurowski V, Rigot B, Croce CM. MicroRNAs in intestinal barrier function, inflammatory bowel disease and related cancers-their effects and therapeutic potentials. Curr Opin Pharmacol. 2017;37:142–150. doi:10.1016/j.coph.2017.10.010
   PubMed Web of Science ®Google Scholar
• Mei Z, He Y, Feng J, et al. MicroRNA-141 promotes the proliferation of non-small cell lung cancer cells by regulating expression of PHLPP1 and PHLPP2. FEBS Lett. 2014;588(17):3055–3061. doi:10.1016/j.febslet.2014.06.020
   PubMed Web of Science ®Google Scholar
• Cai M, Chen S, Hu W. MicroRNA-141 is involved in ulcerative colitis pathogenesis via aiming at CXCL5. J Interferon Cytokine Res. 2017;37(9):415–420. doi:10.1089/jir.2017.0019
   PubMed Web of Science ®Google Scholar
• Ranjha R, Aggarwal S, Bopanna S, Ahuja V, Paul J. Site-specific microRNA expression may lead to different subtypes in ulcerative colitis. PLoS One. 2015;10(11):e0142869. doi:10.1371/journal.pone.0142869
   PubMed Web of Science ®Google Scholar
• Dubois-Camacho K, Diaz-Jimenez D, De la Fuente M, et al. Inhibition of miR-378a-3p by inflammation enhances IL-33 levels: a novel mechanism of alarmin modulation in ulcerative colitis. Front Immunol. 2019;10:2449. doi:10.3389/fimmu.2019.02449
   PubMed Web of Science ®Google Scholar
• Taman H, Fenton CG, Hensel IV, Anderssen E, Florholmen J, Paulssen RH. Transcriptomic landscape of treatment-naive ulcerative colitis. J Crohns Colitis. 2018;12(3):327–336. doi:10.1093/ecco-jcc/jjx139
   PubMed Web of Science ®Google Scholar
• Palmieri O, Mazzoccoli G, Bossa F, et al. Systematic analysis of circadian genes using genome-wide cDNA microarrays in the inflammatory bowel disease transcriptome. Chronobiol Int. 2015;32(7):903–916. doi:10.3109/07420528.2015.1050726
   PubMed Web of Science ®Google Scholar
• Weber CR, Nalle SC, Tretiakova M, Rubin DT, Turner JR. Claudin-1 and claudin-2 expression is elevated in inflammatory bowel disease and may contribute to early neoplastic transformation. Lab Invest. 2008;88(10):1110–1120. doi:10.1038/labinvest.2008.78
   PubMed Web of Science ®Google Scholar
• McCracken AN, Edinger AL. Targeting cancer metabolism at the plasma membrane by limiting amino acid access through SLC6A14. Biochem J. 2015;470(3):e17–e19. doi:10.1042/BJ20150721
   PubMedGoogle Scholar
• Haddad A, Al-Sabbagh MQ, Al-Ani H, et al. Inflammatory bowel disease and prostate cancer risk: a systematic review. Arab J Urol. 2020;18(4):207–212. doi:10.1080/2090598X.2020.1761674
   PubMed Web of Science ®Google Scholar
• Yashiro M. Ulcerative colitis-associated colorectal cancer. World J Gastroenterol. 2014;20(44):16389–16397. doi:10.3748/wjg.v20.i44.16389
   PubMed Web of Science ®Google Scholar
• Taleban S, Elquza E, Gower-Rousseau C, Peyrin-Biroulet L. Cancer and inflammatory bowel disease in the elderly. Dig Liver Dis. 2016;48(10):1105–1111. doi:10.1016/j.dld.2016.05.006
   PubMedGoogle Scholar
• Lee B, Moon KM, Kim CY. Tight junction in the intestinal epithelium: its association with diseases and regulation by phytochemicals. J Immunol Res. 2018;2018:2645465. doi:10.1155/2018/2645465
   PubMed Web of Science ®Google Scholar
• Landy J, Ronde E, English N, et al. Tight junctions in inflammatory bowel diseases and inflammatory bowel disease associated colorectal cancer. World J Gastroenterol. 2016;22(11):3117–3126. doi:10.3748/wjg.v22.i11.3117
   PubMed Web of Science ®Google Scholar
• Rawat M, Nighot M, Al-Sadi R, et al. IL1B increases intestinal tight junction permeability by up-regulation of MIR200C-3p, which degrades occludin mRNA. Gastroenterology. 2020;159(4):1375–1389. doi:10.1053/j.gastro.2020.06.038
   PubMed Web of Science ®Google Scholar
• Shen J, Cheng J, Zhu S, et al. Regulating effect of baicalin on IKK/IKB/NF-kB signaling pathway and apoptosis-related proteins in rats with ulcerative colitis. Int Immunopharmacol. 2019;73:193–200. doi:10.1016/j.intimp.2019.04.052
   PubMed Web of Science ®Google Scholar
• Bing X, Xuelei L, Wanwei D, Linlang L, Keyan C. EGCG maintains Th1/Th2 balance and mitigates ulcerative colitis induced by dextran sulfate sodium through TLR4/MyD88/NF-kappaB signaling pathway in rats. Can J Gastroenterol Hepatol. 2017;2017:3057268. doi:10.1155/2017/3057268
   PubMed Web of Science ®Google Scholar
• Yan S, Xu X, Li Q, Hui Y, Li J, Wei H. [Progress in the study of macrophage activation and ulcerative colitis from the Notch/NF-kappaB/NLRP3 signaling pathway]. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2019;44(10):1174–1178. Chinese.
   PubMedGoogle Scholar